<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2016-04-28</publicationDate>
    
        <volume>9</volume>
        <issue>1</issue>

 
    <startPage>09</startPage>
    <endPage>13</endPage>

	 
      <doi>10.13005/bpj/902</doi>
        <publisherRecordId>6769</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Antimicrobial susceptibility of Escherichia coli Isolates  from Clinical Specimens in Children over a 5-Year Period in Jordan</title>

    <authors>
	 


      <author>
       <name>Al-Shara Mohammad</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	

	

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Faculty of Nursing, Irbid National University Irbid, Jordan</affiliationName>
    

		
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">The present study was conducted to investigate antimicrobial susceptibility pattern of <em>Escherichia coli </em>strains isolated from clinical specimens of Jordanian pediatric patients during a five year period 2005-2009.

A total of 2259 <em>E. coli</em> strains were isolated from different clinical specimens and tested for their susceptibility to commonly used antimicrobial agents.

Overall, high susceptibility rate was observed for nitrofurantoin (90.4%), followed by ciprofloxacin (85.6%), norfloxacin (83.9%), cefotaxime (83.7%), ceftriaxone (82.4%), and gentamicin (80.8%). Lower susceptibility rates were observed for ampicillin (19.8%) followed by amoxicillin-clavulanic acid (26.8%) and cotrimoxazole (31.6%),

Nitrofurantoin was highly effective for <em>E. coli</em> with susceptibility rate of 90.4%. In contrast, ampicillin, amoxicillin-clavulanic acid and cotrimoxazole were found to be ineffective at in vitro for inhibition of the <em>E. coli</em> of pediatric origin.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol9no1/antimicrobial-susceptibility-of-escherichia-coli-isolates-from-clinical-specimens-in-children-over-a-5-year-period-in-jordan/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Antimicrobial resistant</keyword>
      

      
        <keyword> Escherichia coli</keyword>
      

      
        <keyword> pediatric patients</keyword>
      
</keywords>
  </record>
</records>